Intelligent Insulin Pens Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Intelligent insulin pens are used for external insulin delivery, thus offering an easy-to-carry solution to diabetes management The next generation smart insulin pens go far beyond memory storage. They help calculate personalized doses, track glucose continuously, and connect with apps of smartphones to visualize the data. The surge in demand for self-injection devices and accuracy in dosage delivery of insulin drives the market's growth. Growth in research and development projects drives the expansion of the market. Also, the lower cost of insulin pumps and painless injections are further driving the market growth.

MARKET SCOPE

The "Global Intelligent insulin pens Market Analysis to 2031" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of the intelligent insulin pens market with detailed market segmentation by product, connectivity, application, end use, and geography. The report provides key statistics on the market status of the leading intelligent insulin pens market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•  Based on product, the global intelligent insulin pens market is segmented into smart insulin pen, adaptors for conventional pen.
•  Based on connectivity, the global intelligent insulin pens market is segmented into bluetooth, USB.
•  Based on application, the global intelligent insulin pens market is segmented into type 1 diabetes, type 2 diabetes
•  On the basis of end use, the market is segmented into hospitals, clinics, ambulatory surgical centers, home care settings.

MARKET DYNAMICS

Drivers-

•   Rise in the incidences of diabetic diseases.
•   Rapid change in lifestyle and rise in aging populace.
•   Increase in demand for refillable pen, Bluetooth enabled intelligent pens.

Restraints-

•   Stringent process for product approval is the major restraining factor in intelligent insulin pen market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The intelligent insulin pens market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the intelligent insulin pens market in these regions.

IMPACT OF COVID-19 ON INTELLIGENT INSULIN PENSMARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the intelligent insulin pens market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from intelligent insulin pensmarket are anticipated to lucrative growth opportunities in the future with the rising demand for intelligent insulin pens in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the intelligent insulin pens market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•  Novo Nordisk
•  Companion Medical
•  Eli Lilly and Company
•  Diamesco Co. Ltd.
•  Emperra GmbH E-Health Technologies
•  Digital Medics Pvt. Ltd.
•  F. Hoffmann-La Roche AG
•  Insulet Corporation
•  Jiangsu Delfu medical device Co. Ltd.
•  Bigfoot biomedica

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Intelligent Insulin Pens Report Scope